Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Capital Expenditures (2016 - 2019)

Historic Capital Expenditures for Forte Biosciences (FBRX) over the last 4 years, with Q4 2019 value amounting to $89000.0.

  • Forte Biosciences' Capital Expenditures fell 8114.41% to $89000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $162000.0, marking a year-over-year decrease of 9176.83%. This contributed to the annual value of $37000.0 for FY2024, which is 5795.45% down from last year.
  • Latest data reveals that Forte Biosciences reported Capital Expenditures of $89000.0 as of Q4 2019, which was down 8114.41% from -$184000.0 recorded in Q3 2019.
  • Forte Biosciences' 5-year Capital Expenditures high stood at $657000.0 for Q2 2018, and its period low was -$184000.0 during Q3 2019.
  • Over the past 4 years, Forte Biosciences' median Capital Expenditures value was $146500.0 (recorded in 2016), while the average stood at $206875.0.
  • As far as peak fluctuations go, Forte Biosciences' Capital Expenditures soared by 308000.0% in 2017, and later tumbled by 12972.54% in 2019.
  • Forte Biosciences' Capital Expenditures (Quarter) stood at $10000.0 in 2016, then surged by 3080.0% to $318000.0 in 2017, then skyrocketed by 48.43% to $472000.0 in 2018, then tumbled by 81.14% to $89000.0 in 2019.
  • Its Capital Expenditures was $89000.0 in Q4 2019, compared to -$184000.0 in Q3 2019 and $124000.0 in Q2 2019.